Roundup Cancer Ruling Knocks 10% of Bayer's Shares

Roundup Cancer Ruling Knocks 10% of Bayer's Shares

Roundup Cancer Ruling Knocks 10% of Bayer

GALWAY, IRELAND--August 20, 2018--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--German pharmaceuticals and chemicals major Bayer AG (Leverkusan, Germany) saw 10% knocked off the value of its share price after a U.S. court ruled that the Roundup weedkiller was responsible for causing cancer in a groundskeeper.

Within this article: Details court ruling, affected products, potential financial and sales impact

Subscribe Now!(All Fields Required)

Standard Membership - Free